tirzepatide average weight loss first month before and after: realistic results, timelines, and what to expect Mounjaro Weight Loss: What to
Description
The effect of this stimulation is more potent when GIP is co-administered [51]

The medication does not suddenly stop working

If needed, dose adjustments or alternative medications may be required
Step 1: Protect your strength sessions

Kalantaridou SN, Davis SR, Calis KA

The dual glucosedependent insulinotropic polypeptide (GIP) and glucagonlike peptide1 (GLP1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect PubMed accessed October 24, 2025, [DOI] [PMC free article] [PubMed] 34